Clinical Trials Directory

Trials / Sponsors / Johnson & Johnson Private Limited

Johnson & Johnson Private Limited

Industry · 9 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis
Arthritis, Psoriatic
Phase 42025-08-12
RecruitingA Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma
Multiple Myeloma
Phase 42025-05-22
CompletedA Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Die
Diabetes Mellitus
Phase 42020-11-25
CompletedA Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cel
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell
Phase 42019-06-26
CompletedA Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose
Multiple Myeloma
Phase 42019-06-10
CompletedA Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spo
Spondylitis, Ankylosing, Arthritis, Psoriatic
Phase 42019-01-07
CompletedA Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type
Diabetes Mellitus, Type 2
—2018-09-05
CompletedClinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated Wi
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell
—2018-04-28
WithdrawnA Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Met
Prostate Cancer
—2016-05-31